UPSPESA
Live / Applied — Fifth extension granted (statement of use) (as of 31 Dec 2025)
What this means for you
Not registered yet, but its 07 Feb 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97255841
- Mark type
- Stylized text
- Filed
- 07 Feb 2022
- Published for opposition
- 03 Jan 2023
- Attorney of record
- Anna Kurian Shaw
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medical preparations and substances for the treatment of epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, and neurodegenerative diseases; pharmaceutical and medical preparations and substances for the treatment of pediatric epilepsy and epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases; medicinal infusions for the treatment of epilepsy, epilepsy disorders, epileptic encephalopathies, convulsions, seizures, diseases of the central nervous system, neurodegenerative diseases
Owner
- Epygenix Therapeutics, Inc., Plymouth Meeting, PA, US
- Epygenix Therapeutics, Inc., Paramus, NJ, US
Prosecution history
- 01 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2025 — SOU EXTENSION 5 GRANTED
- 19 Aug 2025 — SOU EXTENSION 5 FILED
- 31 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 19 Aug 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Feb 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Feb 2025 — SOU EXTENSION 4 GRANTED
- 11 Feb 2025 — SOU EXTENSION 4 FILED
- 11 Feb 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Aug 2024 — SOU EXTENSION 3 GRANTED
- 20 Aug 2024 — SOU EXTENSION 3 FILED
- 20 Aug 2024 — SOU TEAS EXTENSION RECEIVED
- 16 Jul 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Jul 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED